173 related articles for article (PubMed ID: 27008711)
1. Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression.
Ortiz-Sánchez E; Santiago-López L; Cruz-Domínguez VB; Toledo-Guzmán ME; Hernández-Cueto D; Muñiz-Hernández S; Garrido E; Cantú De León D; García-Carrancá A
Oncotarget; 2016 May; 7(22):31943-54. PubMed ID: 27008711
[TBL] [Abstract][Full Text] [Related]
2. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
3. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
[TBL] [Abstract][Full Text] [Related]
4. Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.
Bortolomai I; Canevari S; Facetti I; De Cecco L; Castellano G; Zacchetti A; Alison MR; Miotti S
Cell Cycle; 2010 Mar; 9(6):1194-206. PubMed ID: 20237414
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri.
Feng D; Peng C; Li C; Zhou Y; Li M; Ling B; Wei H; Tian Z
Oncol Rep; 2009 Nov; 22(5):1129-34. PubMed ID: 19787230
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
7. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
8. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.
López J; Poitevin A; Mendoza-Martínez V; Pérez-Plasencia C; García-Carrancá A
BMC Cancer; 2012 Jan; 12():48. PubMed ID: 22284662
[TBL] [Abstract][Full Text] [Related]
9. High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.
Liu SY; Zheng PS
Oncotarget; 2013 Dec; 4(12):2462-75. PubMed ID: 24318570
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
11. Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.
Wang L; Guo H; Lin C; Yang L; Wang X
Mol Med Rep; 2014 Jun; 9(6):2117-23. PubMed ID: 24676900
[TBL] [Abstract][Full Text] [Related]
12. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
13. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
[TBL] [Abstract][Full Text] [Related]
14. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
16. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
[TBL] [Abstract][Full Text] [Related]
18. A1E reduces stemness and self-renewal in HPV 16-positive cervical cancer stem cells.
Kwon T; Bak Y; Ham SY; Yu DY; Yoon DY
BMC Complement Altern Med; 2016 Feb; 16():42. PubMed ID: 26832364
[TBL] [Abstract][Full Text] [Related]
19. STAT3 correlates with stem cell-related transcription factors in cervical cancer.
Wang H; Cai HB; Chen LL; Zhao WJ; Li P; Wang ZQ; Li Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):891-897. PubMed ID: 26670442
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
